Empagliflozin and Gliclazide: Drug Interaction Guide

Quick answer: This combination requires caution. Empagliflozin and Gliclazide can be used together with adjustments and monitoring.

Interaction severity: Moderate — caution required

How Empagliflozin interacts with Gliclazide

Empagliflozin lowers plasma glucose through SGLT2 inhibition and urinary glucose excretion, while gliclazide closes pancreatic beta-cell ATP-sensitive potassium channels to increase insulin release. Their combined effects increase hypoglycemia risk.

What you should do

Consider reducing the gliclazide dose when empagliflozin is initiated, particularly when glycemic control is near target. Increase glucose monitoring and provide hypoglycemia education.

Key facts

Severity

Moderate — caution required

Mechanism

Empagliflozin lowers plasma glucose through SGLT2 inhibition and urinary glucose excretion, while gliclazide closes panc...

Action

Consider reducing the gliclazide dose when empagliflozin is initiated, particularly when glycemic control is near target...

Important medical disclaimer: This page provides educational information about drug interactions for general reference. It is not a substitute for professional medical advice, diagnosis, or treatment. Always discuss your specific medications with a qualified healthcare provider before starting, stopping, or changing any treatment. About our editorial team.

Frequently asked questions

Can I take Empagliflozin and Gliclazide together?

With caution. Consider reducing the gliclazide dose when empagliflozin is initiated, particularly when glycemic control is near target. Increase glucose monitoring and provide hypoglycemia education.

What is the severity of this interaction?

The interaction between Empagliflozin and Gliclazide is classified as Moderate — caution required. Empagliflozin lowers plasma glucose through SGLT2 inhibition and urinary glucose excretion, while gliclazide closes pancreatic beta-cell ATP-sensitive potassium channels to increase insulin release. Their combined effects increase hypoglycemia risk.

What should I do if I'm prescribed both?

Consider reducing the gliclazide dose when empagliflozin is initiated, particularly when glycemic control is near target. Increase glucose monitoring and provide hypoglycemia education. Always consult your prescribing clinician — do not stop or change medications without medical guidance.

Last reviewed: by iMedic Medical Editorial Team. Our editorial process.